Rabies Vaccine Market Size

Rabies Vaccine Market Size

Rabies Vaccine Market size was valued at USD 1.1 billion in 2023 and is anticipated to witness growth at a CAGR of 4.5% from 2024 and 2032. Increasing awareness about rabies prevention and control, particularly in developing regions where rabies is more prevalent, significantly boosts market demand.

To get key market trends

  Download Free Sample

Additionally, government initiatives and public health campaigns aimed at eradicating rabies, along with the support of international organizations like the World Health Organization (WHO), also play a crucial role. For instance, WHO and its global partners aim to end human deaths from dog-mediated rabies through a comprehensive One Health approach promoting mass dog vaccination, ensuring access to post exposure prophylaxis, health worker training, improved surveillance, and bite prevention through community awareness. Furthermore, advances in vaccine technology, improving the efficacy and safety of rabies vaccines, further stimulates market growth.
 

A rabies vaccine is a biological preparation that provides active acquired immunity to rabies, a viral disease typically transmitted through the bite of an infected animal. Rabies vaccines are used both for pre-exposure prophylaxis, which is recommended for individuals at high risk of rabies exposure (such as veterinarians, animal handlers, and travelers to high-risk areas), and for post-exposure prophylaxis, which is administered after a potential exposure to the rabies virus to prevent the onset of the disease. The vaccines are crucial in controlling and preventing rabies in both humans and animals.